FDA Approves DIVALPROEX SODIUM — NorthStar Rx LLC

NorthStar Rx LLC secured FDA approval for the ANDA covering its generic divalproex sodium tablet, a decision likely to intensify competitive pricing in the long-acting anticonvulsant market. This approval provides the company with a significant revenue stream as it challenges competitors for market share in the established treatment category.